The Pharmacy Times® Immunization Resource Center is a comprehensive resource for clinical news and expert insights on common immunizations, such as flu, zoster, and COVID-19 vaccines.
January 22nd 2025
Engaging with the community, providing transparent information to patients, and using noncoercive methods of encouragement are strategies to reduce COVID-19 vaccine hesitancy.
Pneumococcal Disease Prevention for Older Adults and the Pharmacist’s Role in an Evolving Vaccine Landscape
1.0 Credit / Immunization, Infectious Diseases
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Ac...
1.5 Credits / HIV/AIDS, Infectious Diseases
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization
1.5 Credits / Infectious Diseases
View More
The Essential Role of Pharmacists in Improving Influenza Vaccination Coverage: Strategies to Increase Vaccine ...
1.0 Credit / Immunization, Infectious Diseases
View More
The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake
1.0 Credit / Immunization, Infectious Diseases, Pulmonology
View More
Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Ri...
1.0 Credit / Immunization, Infectious Diseases
View More
Giant Pharmacies Make All Recommended Vaccinations Available to Customers
July 6th 2020Pharmacy Times® interviewed Samir Balile, PharmD, on the safety measures Giant pharmacies are taking to protect patients and staff members upon reopening their doors, as well as the importance of the flu vaccine during COVID-19.
Watch
Study: New 15-Valent Pneumococcal Conjugate Vaccine Meets Immunogenicity and Safety Objectives
July 2nd 2020Results from 2 initial phase 3 studies evaluating an investigational 15-valent pneumococcal conjugate vaccine were recently released, assessing its immunogenicity, safety, and tolerability.
Read More
PharmD Students Cope With Transitions in the Wake of the COVID-19 Pandemic
The COVID-19 pandemic rapidly pushed traditional face-to-face instruction within schools of pharmacy into a fully remote learning environment.
Read More
Study: Children at Greater Risk From COVID-19 Than Previously Believed
May 26th 2020Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.
Read More